Building the world’s first scientific superintelligence platform and fully autonomous labs for life, chemical, and materials sciences.

Ignota Labs applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues, rescuing promising but failing drugs and bringing new life to abandoned projects and new hope to patients.

Glyphic Bio is redefining proteomics with next-generation protein sequencing. While DNA provides the blueprint, proteins determine what actually happens in the body. Glyphic Biotechnologies is developing a first-of-its-kind platform to give researchers unprecedented insights into biology and disease, pushing the boundaries of what’s possible in protein analysis.

March Biosciences is developing advanced cell therapies, targeting complex diseases like cancer and genetic disorders through precision medicine approaches. Their lead asset, MB-105, selectively targets CD5, a widely expressed antigen both in normal and malignant T-cells.

Groq provide fast AI inference in the cloud and in on-prem AI compute centers. Their core product is the GroqChip, a unique tensor streaming processor (TSP) architecture specifically built to accelerate AI workloads, such as deep learning, natural language processing, and computer vision

PathPresenter is an enterprise workflow platform powered by Microsoft Azure Cloud, offering exceptional imaging performance and data integrity, with the flexibility to function in a hybrid data environment.

Komo Biosciences enables accelerated development and manufacturing of therapeutics by translating the utility of high-efficiency integrases to high-efficiency therapeutic development and manufacturing processes.

Latus Bio is developing curative medicines for neurological diseases, enabled by unprecedented AAV capsids that unlock new possibilities for patient care.

Rubedo discovers and develops medicines to keep you biologically young by targeting the pathologic cells that drive aging.

Aether uses its state of the art platform to rapidly engineer enzymes, enabling our customers to manufacture complex and novel products at fractional cost.

Developing the next generation of induced-proximity medicines

Wearable neurotechnology that augments sleep, attention, and ultimately the human experience.

Tiny Health is the first gut health test for moms and babies 0-3 years. They detect gut imbalances and course correct early on.

Ozlo is on a mission to clinically enhance rest without pharmaceutical intervention – and the associated side effects – to improve both wakefulness and the quality of mental and physical well-being.

Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of machine learning, biological engineering, and medicine—pioneering generative biology to create breakthrough medicines.

UnNatural Products creates entirely new drugs by engineering synthetic molecules to mimic nature’s macrocycles. Their platform produces passively permeable, macrocyclic peptides that access and address traditionally undruggable targets.

Harbinger Health is a biotechnology company pioneering new technologies to fundamentally change cancer screening and detection.

Ashvattha Therapeutics is advancing a new class of clinical-stage nanomedicine therapeutics that traverse tissue barriers to selectively target activated cells in regions of inflammation.

Starling Medical is building an at home urine diagnostic remote patient monitoring platform that can seamlessly integrate into anybody’s bathroom routine.

Perceptive is integrating imaging and robotics for modern dentistry solutions.